skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 6,173  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The 'Digital Twin' to enable the vision of precision cardiology
Material Type:
Article
Add to My Research

The 'Digital Twin' to enable the vision of precision cardiology

European heart journal, 2020-12, Vol.41 (48), p.4556-4564 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa159 ;PMID: 32128588

Full text available

2
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Material Type:
Article
Add to My Research

Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine

European heart journal, 2021-01, Vol.42 (2), p.152-161 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Attribution - NonCommercial ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa736 ;PMID: 33099609

Full text available

3
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
Material Type:
Article
Add to My Research

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

European journal of heart failure, 2017, Vol.19 (1), p.9-42 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;ISSN: 1879-0844 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.654

Digital Resources/Online E-Resources

4
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure
Material Type:
Article
Add to My Research

Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure

Journal of the American College of Cardiology, 2021-03, Vol.77 (11), p.1397-1407 [Peer Reviewed Journal]

2021 The Authors ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.01.044 ;PMID: 33736821

Full text available

5
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

The New England journal of medicine, 2021-10, Vol.385 (16), p.1451-1461 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107038 ;PMID: 34449189

Full text available

6
Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity
Material Type:
Article
Add to My Research

Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity

Circulation (New York, N.Y.), 2017-11, Vol.136 (21), p.2085-2087 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circulationaha.117.030571 ;PMID: 29158217

Full text available

7
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
Material Type:
Article
Add to My Research

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

European Heart Journal, 2020-11, Vol.41 (42), p.4092-4099 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;2020. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa659 ;PMID: 32860034

Digital Resources/Online E-Resources

8
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
Material Type:
Article
Add to My Research

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

European heart journal, 2011-06, Vol.32 (11), p.1345-1361 [Peer Reviewed Journal]

2015 INIST-CNRS ;Distributed under a Creative Commons Attribution 4.0 International License ;Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2011. For permissions please email: journals.permissions@oup.com 2011 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehr112 ;PMID: 21531743

Full text available

9
Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement
Material Type:
Article
Add to My Research

Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement

Journal of the American College of Cardiology, 2019-12, Vol.74 (22), p.2728-2739 [Peer Reviewed Journal]

2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019. The Authors ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.09.054 ;PMID: 31779788

Full text available

10
The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study
Material Type:
Article
Add to My Research

The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study

European journal of heart failure, 2019-08, Vol.21 (8), p.965-973 [Peer Reviewed Journal]

Attribution - NonCommercial - NoDerivatives ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1482

Digital Resources/Online E-Resources

11
Reduced reticulum–mitochondria Ca2+ transfer is an early and reversible trigger of mitochondrial dysfunctions in diabetic cardiomyopathy
Material Type:
Article
Add to My Research

Reduced reticulum–mitochondria Ca2+ transfer is an early and reversible trigger of mitochondrial dysfunctions in diabetic cardiomyopathy

Basic research in cardiology, 2020-11, Vol.115 (6), p.74-74, Article 74 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0300-8428 ;EISSN: 1435-1803 ;DOI: 10.1007/s00395-020-00835-7 ;PMID: 33258101

Full text available

12
Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges
Material Type:
Article
Add to My Research

Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges

Heart (British Cardiac Society), 2021-09, Vol.107 (17), p.1369-1375 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2020-318760 ;PMID: 33795379

Full text available

13
Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy
Material Type:
Article
Add to My Research

Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy

European journal of heart failure, 2019-01, Vol.21 (1), p.74-85 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1333

Digital Resources/Online E-Resources

14
Microparticles, Vascular Function, and Atherothrombosis
Material Type:
Article
Add to My Research

Microparticles, Vascular Function, and Atherothrombosis

Circulation research, 2011-08, Vol.109 (5), p.593-606 [Peer Reviewed Journal]

2011 American Heart Association, Inc. ;2015 INIST-CNRS ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.110.233163 ;PMID: 21852557 ;CODEN: CIRUAL

Full text available

15
Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies
Material Type:
Article
Add to My Research

Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

Circulation (New York, N.Y.), 2019-07, Vol.140 (4), p.293-302 [Peer Reviewed Journal]

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.039410 ;PMID: 31155932

Full text available

16
Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France
Material Type:
Article
Add to My Research

Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France

European heart journal, 2019-11, Vol.40 (43), p.3516-3525 [Peer Reviewed Journal]

The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz458 ;PMID: 31362307

Full text available

17
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
Material Type:
Article
Add to My Research

Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology

European journal of heart failure, 2019-03, Vol.21 (3), p.272-285 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1406 ;PMID: 30714667

Digital Resources/Online E-Resources

18
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Material Type:
Article
Add to My Research

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

European heart journal, 2020-06, Vol.41 (24), p.2313-2330 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz962 ;PMID: 32052833

Full text available

19
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
Material Type:
Article
Add to My Research

CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction

Canadian journal of cardiology, 2021-04, Vol.37 (4), p.531-546 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0828-282X ;EISSN: 1916-7075 ;DOI: 10.1016/j.cjca.2021.01.017 ;PMID: 33827756

Digital Resources/Online E-Resources

20
Microvesicles as cell-cell messengers in cardiovascular diseases
Material Type:
Article
Add to My Research

Microvesicles as cell-cell messengers in cardiovascular diseases

Circulation research, 2014-01, Vol.114 (2), p.345-353 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/circresaha.113.300858 ;PMID: 24436430

Full text available

Results 1 - 20 of 6,173  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (5,578)

Refine My Results

Creation Date 

From To
  1. Before 1990  (22)
  2. 1990 To 1997  (51)
  3. 1998 To 2005  (148)
  4. 2006 To 2014  (997)
  5. After 2014  (4,866)
  6. More options open sub menu

Language 

  1. English  (5,907)
  2. Japanese  (602)
  3. French  (276)
  4. Norwegian  (15)
  5. Portuguese  (7)
  6. Ukrainian  (4)
  7. Spanish  (4)
  8. Russian  (2)
  9. Polish  (1)
  10. Czech  (1)
  11. More options open sub menu

Searching Remote Databases, Please Wait